Marshall Wace’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-208,532
| Closed | -$282K | – | 2887 |
|
|
2025
Q1 | $282K | Buy |
208,532
+154,652
| +287% | +$209K | ﹤0.01% | 2168 |
|
|
2024
Q4 | $710K | Buy |
+53,880
| New | +$710K | ﹤0.01% | 1760 |
|
|
2024
Q2 | – | Sell |
-130,935
| Closed | -$1.95M | – | 2599 |
|
|
2024
Q1 | $1.95M | Buy |
+130,935
| New | +$1.95M | ﹤0.01% | 1200 |
|
|
2023
Q4 | – | Sell |
-73,921
| Closed | -$1.28M | – | 2183 |
|
|
2023
Q3 | $1.28M | Buy |
+73,921
| New | +$1.28M | ﹤0.01% | 1193 |
|
|
2023
Q2 | – | Sell |
-37,354
| Closed | -$994K | – | 2405 |
|
|
2023
Q1 | $994K | Sell |
37,354
-28,466
| -43% | -$757K | ﹤0.01% | 1416 |
|
|
2022
Q4 | $1.27M | Buy |
+65,820
| New | +$1.27M | ﹤0.01% | 1514 |
|
|
2022
Q3 | – | Sell |
-46,414
| Closed | -$371K | – | 2959 |
|
|
2022
Q2 | $371K | Buy |
+46,414
| New | +$371K | ﹤0.01% | 2266 |
|